european end-to-end CDMO company, pharma services
  • About us
    • History
    • Leaderships
    • Team
    • EU grants
    • Requests for Proposal
    • Sustainability – ESG
    • Bussines strategy
    • Quality policy
    • Virtual Tour
  • Services
    • Drug Substance Manufacturing
    • Fill & Finish
    • Gene to Vial: End-to-End Development
    • Process Development
    • Analytics 
    • Cell Line Development & Banking
  • Science Hub
    • Science News
    • Resources
  • News & Events
    • Press releases
    • Events
    • Content to download
  • Investors
    • Corporate documents
    • Shareholders and shares
    • Periodic reports
    • Current reports
    • Sustainability reports
    • Corporate governance at Mabion
    • Financial data
    • For Investors
    • Calendar
  • Contact us
    • Contact form
    • Contact for investors
    • Contact for media
    • Careers
  • EN
  • Science News
  • Resources

Drug product

Rapid Microbiological Methods (RMMs) enhance sterile drug quality control

Rapid Microbiological Methods in Quality Control of Sterile Drugs

Contamination, Drug product, Microbiology
downstream development

The Role of Downstream Development in Ensuring Biologic Product Purity and Quality

Drug product, Manufacturing
aseptic filling

Aseptic Filling in Modern Pharmaceutical Manufacturing

Drug product, Manufacturing
stable cell line development

Role of Stable Cell Line in Biopharmaceutical Manufacturing 

Drug development, Drug product, Manufacturing
CHO K1 cell line 27 hours

CHO Cell Lines for Recombinant Protein Production

Drug development, Drug product, Manufacturing
leading european cdmo

Leading European CDMO for Drug Product Manufacturing

Drug development, Drug product, Manufacturing
Host Cell Proteins

Qualitative Analysis of Host Cell Proteins using Mass Spectrometry

Analytics, Drug development, Drug product, Drug substance
Immunogenicity Impact on Efficacy and Safety of Biosimilars

Impact of immunogenicity on efficacy and safety of biosimilars – importance of ADA and nAb testing during the clinical development

Biologics, Drug product

Contact

Find out how we may support your business.

bd@mabion.eu

Mabion

gen. Mariana Langiewicza 60
95-050 Konstantynów Łódzki
Poland

+48 42 207 78 90

    Mabion
    • Privacy policy
    • Services
    • Investors
    • News&Events
    • Contact us

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Page Sitemap.

    Powered by

    Veneo